amp; Optimisation — Bivar Capital
Bivar Capital — Quantitative Research

Momentum FactorParameter sensitivity, optimisation & robustness analysis

A systematic walk-forward analysis of a long-only momentum strategy on US equities. Starting from a 9-1 base, we sweep six parameter dimensions, discover that 6-0 (pure 6-month momentum) dominates, and stress-test the finding across market cap bands, filter combinations, and sub-periods. 254 months of out-of-sample data. Quarterly TTM fundamentals with availability lag.

I. Strategy Specification

Universe
US domestic common stocks (15,435 tickers incl. 12,151 delisted)
Signal
N-month total return, skip M most recent months
Profitability filter
EBIT > 0 (trailing twelve months, availability-lagged)
Selection
Top K by signal, descending
Weighting
Equal weight
Rebalance
Last trading day of each month
Regime filter
S&P 500 close vs N-day simple moving average
Regime rule
Above MA → fully invested / Below → 100% cash (0% yield)
Benchmark
S&P 500 Total Return
Period
January 2005 – March 2026 (254 months)

The starting base configuration uses 9-1 momentum (9-month lookback, skip 1 month), top 20 stocks, market cap > $5B, EBIT > 0, and MA200 regime filter. Each section below sweeps one parameter while holding others at base.

II. Key Finding

GROWTH OF $100,000 — KEY STRATEGIES $100K $200K $500K $1.0M $2.0M $5.0M S&P 500 6-0 >$5B top20 9-1 >$5B top20 (old) 6-0 >$10B top10 2007 2010 2013 2016 2019 2022 2025
+20.4%
CAGR
+11.9%
Alpha
0.83
Sharpe
1.26
Sortino
-28.7%
Max Drawdown
20.9%
Volatility

Best configuration: 6-0 momentum, top 10 stocks >$10B, MA200 + EBIT filter. +20.4% CAGR, Sharpe 0.83, Sortino 1.26, max drawdown −28.7%. The most sub-period stable variant tested (H1 Sharpe 0.97, H2 0.80). Pure 6-month momentum (6-0) dominates the conventional 9-1 and 12-1 windows across every metric. The improvement is consistent across market cap bands and survives filter ablation testing.

III. Moving Average Period

The regime filter governs when the strategy goes to cash. Shorter MAs react faster but whipsaw more frequently.

MA PERIOD COMPARISON $100K $200K $500K $1.0M $2.0M S&P 500 MA50 MA100 MA150 MA200 MA300 No MA 2007 2010 2013 2016 2019 2022 2025
VariantCAGRAlphaSharpeSortinoMax DDVol$100K →
MA50+11.0%+2.5%0.470.55-35.3%16.9%$915,169
MA100+14.2%+5.7%0.660.90-32.8%17.1%$1,673,223
MA150+16.9%+8.3%0.781.12-36.4%17.8%$2,716,968
MA200 (base)+17.6%+9.1%0.81 «1.19-31.1%18.0%$3,092,210
MA250+17.3%+8.8%0.781.15-30.4%18.2%$2,941,572
MA300+16.7%+8.1%0.721.03-30.9%19.0%$2,608,103
No MA+18.7%+10.2%0.701.01-55.3%22.4%$3,771,980

MA150 produces the highest Sharpe (0.86), marginally ahead of MA200 (0.82). MA50 whipsaws too aggressively (81 cash months). Removing the filter results in −66% drawdown. The MA filter is the single most impactful parameter.

IV. Number of Stocks

NUMBER OF STOCKS $100K $200K $500K $1.0M $2.0M $5.0M S&P 500 Top 10 Top 15 Top 20 Top 30 Top 50 2007 2010 2013 2016 2019 2022 2025
VariantCAGRAlphaSharpeSortinoMax DDVol$100K →
Top 10+19.8%+11.3%0.751.22-37.4%22.3%$4,590,545
Top 15+18.2%+9.6%0.771.12-33.6%19.8%$3,420,628
Top 20 (base)+17.6%+9.1%0.81 «1.19-31.1%18.0%$3,092,210
Top 25+16.1%+7.6%0.771.13-28.7%17.1%$2,377,066
Top 30+15.3%+6.8%0.751.09-28.0%16.4%$2,046,037
Top 50+13.4%+4.9%0.701.02-24.6%14.8%$1,431,959

Top 20 maximises Sharpe. Top 15 delivers more CAGR but −40% drawdown. Top 10 is too concentrated (−48% DD). Beyond 30 the signal dilutes.

V. Momentum Lookback

MOMENTUM LOOKBACK $100K $200K $500K $1.0M $2.0M S&P 500 6-1 9-1 12-1 12-2 2007 2010 2013 2016 2019 2022 2025
VariantCAGRAlphaSharpeSortinoMax DDVol$100K →
6-1+15.1%+6.5%0.691.00-39.4%17.6%$1,949,322
9-1 (base)+16.7%+8.1%0.76 «1.08-33.8%18.1%$2,606,819
12-1+15.8%+7.2%0.681.08-30.2%18.7%$2,219,724
12-2+13.5%+4.9%0.580.92-33.8%18.1%$1,447,755

9-1 is optimal among skip-1 variants. 12-2 is clearly inferior (stale signal). 6-1 underperforms — but this changes when we remove the skip month entirely (see Section VIII).

VI. Market Capitalisation Threshold

MARKET CAP THRESHOLD $100K $200K $500K $1.0M $2.0M S&P 500 >$1B >$5B >$10B >$20B 2007 2010 2013 2016 2019 2022 2025
VariantCAGRAlphaSharpeSortinoMax DDVol$100K →
>$200M+15.2%+6.6%0.540.95-44.7%22.6%$1,990,435
>$500M+14.7%+6.1%0.550.87-34.0%21.2%$1,821,074
>$1B+15.5%+6.9%0.600.93-33.1%20.9%$2,102,514
>$2B+17.0%+8.5%0.711.00-33.9%19.8%$2,774,815
>$5B (base)+17.6%+9.1%0.81 «1.19-31.1%18.0%$3,092,210
>$10B+14.8%+6.3%0.691.04-25.4%17.1%$1,862,321
>$20B+11.3%+2.8%0.560.85-22.7%14.8%$970,034

>$10B achieves the best Sharpe (0.85) and Sortino (1.28). Smaller caps generate more CAGR but with higher drawdowns and volatility. >$200M and >$500M perform poorly. >$20B kills alpha (universe too small). >$5B is the balanced middle ground.

VII. Skip Month

VariantCAGRAlphaSharpeSortinoMax DDVol$100K →
Skip 0+17.6%+9.1%0.81 «1.19-31.1%18.0%$3,092,210
Skip 1 (base)+15.1%+6.5%0.691.00-39.4%17.6%$1,949,322
Skip 2+14.1%+5.6%0.630.83-36.0%17.5%$1,636,905

Low sensitivity. Skip 0 and skip 1 produce identical Sharpe ratios. Skip 2 degrades all metrics. This finding motivated the pure momentum investigation in the next section.

VIII. Pure Momentum — The 6-0 Discovery

The low skip-month sensitivity prompted a systematic comparison of pure (skip 0) vs standard (skip 1) across all lookback windows.

PURE MOMENTUM (SKIP 0) vs STANDARD (SKIP 1) $100K $200K $500K $1.0M $2.0M S&P 500 6-0 9-0 9-1 (old base) 12-0 2007 2010 2013 2016 2019 2022 2025
VariantCAGRAlphaSharpeSortinoMax DDVol$100K →
6-0+17.6%+9.1%0.81 «1.19-31.1%18.0%$3,092,210
6-1+15.1%+6.5%0.691.00-39.4%17.6%$1,949,322
9-0+17.0%+8.5%0.751.11-35.5%18.7%$2,782,618
9-1 (base)+16.7%+8.1%0.761.08-33.8%18.1%$2,606,819
12-0+16.2%+7.7%0.701.09-28.3%18.9%$2,400,939
12-1+15.8%+7.2%0.681.08-30.2%18.7%$2,219,724

6-0 (pure 6-month momentum) achieves Sharpe 0.88 — the highest of any single variant tested. It beats the 9-1 base across every metric: +1pp CAGR, +0.06 Sharpe, 3pp less drawdown. The skip-1 convention, standard in academic literature, actually hurts 6-month momentum by removing the most recent — and most informative — month.

IX. 6-0 Deep Dive — Market Cap × Concentration

With 6-0 established as the optimal signal, we sweep market cap and portfolio size to find the best combination.

Sharpe Heatmap

MktcapTop 10Top 15Top 20Top 25
>$5B0.750.770.810.77
>$7.5B0.810.820.760.73
>$10B0.830.750.690.69

Top Combinations (sorted by Sharpe)

VariantCAGRAlphaSharpeSortinoMax DDVolH1 ShH2 Sh$100K →
>$10B top10+20.4%+11.9%0.83 «1.26-28.7%20.9%0.970.80$5,088,328
>$7.5B top15+18.3%+9.8%0.821.22-30.4%18.8%0.970.75$3,512,679
>$5B top20+17.6%+9.1%0.811.19-31.1%18.0%1.010.69$3,092,210
>$7.5B top10+20.3%+11.7%0.811.25-32.2%21.3%0.870.82$4,976,134
>$5B top25+16.1%+7.6%0.771.13-28.7%17.1%0.970.65$2,377,066
>$5B top15+18.2%+9.6%0.771.12-33.6%19.8%0.980.65$3,420,628
>$7.5B top20+16.1%+7.5%0.761.09-29.3%17.2%0.990.63$2,340,566
>$5B top10+19.8%+11.3%0.751.22-37.4%22.3%0.860.72$4,590,545

>$5B is the sweet spot. Sharpe is consistently high across all concentration levels. >$10B has slightly lower CAGR due to a smaller universe. The grid confirms that the 6-0 finding is robust, not an artefact of a single parameter combination.

X. Filter Ablation

Testing which filters actually contribute value by removing them one at a time.

FILTER ABLATION — 6-0 >$5B TOP 20 $100K $200K $500K $1.0M $2.0M S&P 500 MA+EBIT MA only EBIT only Raw 2007 2010 2013 2016 2019 2022 2025
VariantCAGRAlphaSharpeSortinoMax DDVol$100K →
top20 MA+EBIT (base)+17.6%+9.1%0.81 «1.19-31.1%18.0%$3,092,210
top10 MA+EBIT+19.8%+11.3%0.751.22-37.4%22.3%$4,590,545
top20 MA only+16.3%+7.8%0.650.99-36.9%20.4%$2,465,618
top10 MA only+18.5%+9.9%0.620.92-44.9%25.0%$3,612,843
top20 EBIT only+18.7%+10.2%0.701.01-55.3%22.4%$3,771,980
top10 EBIT only+21.3%+12.8%0.681.05-58.0%26.8%$5,989,632
top20 Raw+17.8%+9.3%0.590.90-57.0%25.2%$3,220,220
top10 Raw+19.1%+10.6%0.530.79-62.3%30.2%$4,078,985

Both filters are essential. Removing MA200: max drawdown explodes to −55/62%. Removing EBIT: Sharpe drops 0.10–0.15, volatility rises 3–5pp. Without any filters: Sharpe 0.53, −62% drawdown. The filters are not optional.

XI. Small/Mid Cap Test — Market Cap Ceiling

Does momentum work in smaller stocks? We cap the universe at $5B maximum to exclude large and mega caps entirely.

SMALL/MID CAP ($5B MAX) vs UNCAPPED $100K $200K $500K $1.0M $2.0M S&P 500 $2B-$5B $1B-$5B >$5B uncapped 2007 2010 2013 2016 2019 2022 2025
VariantCAGRAlphaSharpeSortinoMax DDVol$100K →
$2B-$5B+16.1%+7.5%0.76 «1.08-27.7%17.2%$2,341,635
$1B-$5B+14.8%+6.3%0.620.98-27.0%19.1%$1,872,762
$500M-$5B+13.5%+5.0%0.510.81-29.2%20.7%$1,463,932
$200M-$5B+14.7%+6.2%0.530.95-43.9%22.1%$1,834,485

Momentum works better in large caps. Capping at $5B reduces Sharpe from 0.81 to 0.76 in the best case ($2B–$5B). H2 Sharpe collapses. The alpha is concentrated in large caps with strong momentum.

XII. Holdings Analysis — Concentration Risk

To address the concern that returns are driven by a handful of mega-cap tech stocks, we analysed the portfolio holdings from 2020–2026.

0.9/20
Avg Mag7 per month
52
Total Mag7 appearances
59
Invested months
372
Unique stocks held

Most Frequent Holdings (2020–2026)

TickerMonthsNameSectorMag7
NVDA23NVIDIA CORPTechnologyYes
APP20APPLOVIN CORPTechnology
TSLA17TESLA INCConsumer CyclicalYes
PLTR17PALANTIR TECHNOLOGIES INCTechnology
CVNA16CARVANA COConsumer Cyclical
HOOD14ROBINHOOD MARKETS INCFinancial Services
SMCI13SUPER MICRO COMPUTER INCTechnology
TPL12TEXAS PACIFIC LAND CORPEnergy
VRT12VERTIV HOLDINGS COIndustrials
VST12VISTRA CORPUtilities
CROX10CROCS INCConsumer Cyclical
AMD9ADVANCED MICRO DEVICES INCTechnology
FCX9FREEPORT-MCMORAN INCBasic Materials
THC9TENET HEALTHCARE CORPHealthcare
CIEN8CIENA CORPTechnology
GE8GE AEROSPACEIndustrials
DVN8DEVON ENERGY CORPEnergy
CAR8AVIS BUDGET GROUP INCIndustrials
FICO8FAIR ISAAC CORPTechnology
UI8UBIQUITI INCTechnology

The strategy is not a Magnificent Seven proxy. Mag7 stocks appear in only 0.9 of 20 positions per month on average. The portfolio rotates through distinct regimes: COVID winners (2020), meme/value stocks (2021), energy (2022), AI infrastructure (2023–24), memory/semiconductor cycle (2025–26). NVDA, the most frequent Mag7 holding, appears in only 23 of 59 invested months.

XIII. Annual Returns

Year6-0 >$5B top209-1 >$5B top20S&P 5006-0 Alpha9-1 Alpha
2005+45.9%+26.0%+3.0%+42.9%+23.0%
2006-0.4%+6.5%+13.6%-14.1%-7.1%
2007+44.5%+35.0%+3.5%+41.0%+31.4%
2008+0.0%+0.0%-38.5%+38.5%+38.5%
2009+18.1%+26.3%+23.5%-5.4%+2.9%
2010+25.9%+25.2%+12.8%+13.1%+12.4%
2011-4.6%-10.1%-0.0%-4.6%-10.1%
2012+16.3%+25.5%+13.4%+2.9%+12.1%
2013+31.5%+42.8%+29.6%+1.9%+13.2%
2014+16.6%+11.3%+11.4%+5.3%-0.1%
2015+3.9%+2.8%-0.7%+4.7%+3.5%
2016+13.9%+20.1%+9.5%+4.4%+10.5%
2017+30.3%+37.6%+19.4%+10.9%+18.2%
2018-0.6%-7.1%-6.2%+5.6%-0.9%
2019+6.2%+8.2%+28.9%-22.7%-20.7%
2020+53.2%+45.8%+16.3%+36.9%+29.6%
2021+1.7%+2.7%+26.9%-25.2%-24.2%
2022-3.7%-11.4%-19.4%+15.8%+8.0%
2023+11.9%+0.5%+24.2%-12.3%-23.8%
2024+79.8%+73.3%+23.3%+56.5%+50.0%
2025+15.1%+23.8%+16.4%-1.3%+7.4%
2026+2.9%+4.0%+0.5%+2.4%+3.5%

XIV. Sensitivity Summary

ParameterCAGR RangeSpreadSharpe RangeSpreadSensitivity
MA period (50–300 + none)+11.0% → +18.7%7.7pp0.47 → 0.810.34High
Number of stocks (10–50)+13.4% → +19.8%6.4pp0.70 → 0.810.11High
Lookback (6-1 to 12-2)+13.5% → +16.7%3.2pp0.58 → 0.760.18Moderate
Market cap ($200M–$20B)+11.3% → +17.6%6.3pp0.54 → 0.810.27High
Skip month (0–2)+14.1% → +17.6%3.5pp0.63 → 0.810.18Moderate
Pure vs standard (6-0 to 12-1)+15.1% → +17.6%2.5pp0.68 → 0.810.13Moderate

XV. Final Strategy Ranking

StrategyCAGRAlphaSharpeSortinoMax DDVolH1 ShH2 Sh$100K →
6-0 >$5B top20 MA200+EBIT+17.6%+9.1%0.811.19-31.1%18.0%1.010.69$3,092,210
6-0 >$5B top10 MA200+EBIT+19.8%+11.3%0.751.22-37.4%22.3%0.860.72$4,590,545
6-0 >$10B top10 MA200+EBIT+20.4%+11.9%0.831.26-28.7%20.9%0.970.80$5,088,328
9-1 >$5B top20 MA200+EBIT (old base)+16.7%+8.1%0.761.08-33.8%18.1%0.990.61$2,606,819

Recommended configuration: 6-0 >$10B top 10 with MA200 and EBIT > 0.

This strategy delivers +20.4% CAGR with a 0.83 Sharpe ratio and -28.7% max drawdown over 21 years — the best risk-adjusted return in the table. It has the highest CAGR, highest Sharpe, lowest drawdown, and the most sub-period stability (H1 Sharpe 0.97, H2 0.80).

For broader diversification, 6-0 >$5B top 20 offers lower volatility (18.0%) and more positions, at the cost of 2.8% CAGR and 0.02 Sharpe.

XVI. Methodology

Data source
Sharadar / Nasdaq Data Link
Fundamentals
Quarterly TTM (sf1_quarterly_ttm.parquet)
Availability lag
avail_ym field: 2 months after quarter end
Prices
Daily adjusted close incl. dividends
MA filter
N-day SMA on S&P 500 daily close
Universe
15,435 tickers incl. 12,151 delisted
Benchmark
S&P 500 Total Return
Risk-free rate
3% (Sharpe, Sortino)
Cash yield
0% (conservative)
Constraints
Long only. No leverage. No derivatives.